Company Filing History:
Years Active: 2021
Title: Meng-Hua Lee: Innovator in Cancer Treatment
Introduction
Meng-Hua Lee is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. His innovative approach utilizes antipsychotic phenothiazine derivatives to develop effective cancer treatments.
Latest Patents
Meng-Hua Lee holds a patent for a pharmaceutical composition aimed at treating cancer using phenothiazine. The patent details the use of antipsychotic phenothiazine derivatives for cancer treatment. It also outlines methods for manufacturing a medicament and pharmaceutical compositions for treating cancer, as well as preventing or delaying cancer recurrence based on trifluoperazine. Furthermore, the invention includes applications for treating KRAS mutant non-small cell lung cancer (NSCLC) using thioridazine and its enantiomers.
Career Highlights
Meng-Hua Lee is affiliated with National Yang Ming Chiao Tung University, where he continues to advance research in pharmaceutical sciences. His work has garnered attention for its potential impact on cancer therapies.
Collaborations
Some of his notable coworkers include Chi-Ying Huang and Jane Hsiao, who contribute to the collaborative research efforts in his field.
Conclusion
Meng-Hua Lee's innovative work in cancer treatment exemplifies the intersection of pharmaceutical research and practical application. His contributions are paving the way for new therapeutic options in oncology.